Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
XLO holding history
Xilio Therapeutics, Inc. in every 13F filed by Gilead Sciences, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XLO overviewAll 13F holders of XLOFull Q2 2026 holdings
- Shares (Q2 2026)
- 650,389
- Value
- $6.23M
- % of portfolio
- 0.4%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 650,389 | $6.23M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 650,389 | $5.47M | 0.3% | 00.0% | UnchangedConverted for a 1-for-14 split | Holders |
| Q4 2025 | 9,105,451 | $5.83M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 9,105,451 | $7.67M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2025 | 9,105,451 | $6.19M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 9,105,451 | $6.60M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2024 | 9,105,451 | $8.70M | 0.6% | – | No prior filing | Holders |